EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Results of the American Venous Forum research retreat on C2 disease confirms that the biology of varicose veins including etiology, progression, and novel therapeutics, as well as disparities, are top research priorities

Ulka Sachdev-Ost, Andrea Obi, Eri Fukaya, Cassius Ochoa Chaar, Scott Robinson, Limael Rodriquez, Khan Nguyen, Peter Henke, Andre Van Rij, Benjamin Jacobs

Journal of Vascular Surgery: Venous and Lymphatic Disorders · 2026-07 · 14 (4) · 102463

DOI: 10.1016/j.jvsv.2026.102463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2026-07. Verfasst von Ulka Sachdev-Ost und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of South Florida, Tampa, FL. Electronic address: us22@usf.edu. Hauptthemen laut MEDLINE: Varicose Veins, Biomedical Research, Healthcare Disparities. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Funding for research in varicose vein disease has traditionally been poor, despite its negative impact and high prevalence, affecting millions of people. To identify high-yield topics that would benefit from dedicated research and funding, the American Venous Forum (AVF) Research Committee hosted a Research Priorities Retreat for C2 disease. We hypothesized that an open forum of brief presentations, open panel discussions, and forced rank surveys would identify scientific priorities in C2 disease and provide a foundation for designing future research efforts. METHODS: The initial list of topics for discussion and potential speakers was reviewed by members of the 2024 AVF Research Committee based on recently published guidelines on C2 disease and on scientific experience. All participants were required to participate synchronously during the virtual event. The format prioritized high-yield topics, opportunities for robust discussion, and transparency for registered AVF members. A force rank survey was administered before and after the retreat to committee members, panel speakers, and discussions. In addition, registrants who attended were also given the opportunity to rank topics after discussion. RESULTS: The speakers, discussants, and committee members (n = 12) who ranked topics immediately before and after the retreat represented a multidisciplinary team from vascular surgery, interventional radiology, vascular medicine, and phlebology, with clinical and scientific doctorate experience. Understanding the underlying etiologies and the biological mechanisms and identifying new medical therapies were considered the highest research priorities, followed by ways to achieve health care equity for patients with C2 disease. CONCLUSIONS: This study represents a multidisciplinary effort by the AVF Research Committee to identify research priorities in C2 disease. The retreat was carefully planned and transparently executed, providing a mechanism to inform future research efforts of the AVF. Future biologic therapies to target and improve the treatment of varicose veins and health care equity were the top priorities in post event ranking. The resulting document may provide guidance for investigators hoping to pursue research in C2 varicose vein disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Varicose VeinsBiomedical ResearchHealthcare DisparitiesHumansUnited StatesDisease Progression

Stichwörter der Autor:innen

American Venous Forum Research CommitteeResearch prioritiesVaricose veins

Autor:innen und Institutionen

  • University of South Florida, Tampa, FL. Electronic address: us22@usf.edu.
  • University of Michigan, Ann Arbor, MI.
  • Stanford University, Stanford, CA.
  • Yale University, New Haven, CT.
  • University of Florida, Gainesville, FL.
  • Texas Vascular and Imaging, Houston, TX.

Zitieren

APA

Sachdev-Ost, U., Obi, A., Fukaya, E., Chaar, C. O., Robinson, S., Rodriquez, L., Nguyen, K., Henke, P., Van Rij, A., & Jacobs, B. (2026). Results of the American Venous Forum research retreat on C2 disease confirms that the biology of varicose veins including etiology, progression, and novel therapeutics, as well as disparities, are top research priorities. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 14(4), 102463. https://doi.org/10.1016/j.jvsv.2026.102463

Vancouver

Sachdev-Ost U, Obi A, Fukaya E, Chaar CO, Robinson S, Rodriquez L, et al. Results of the American Venous Forum research retreat on C2 disease confirms that the biology of varicose veins including etiology, progression, and novel therapeutics, as well as disparities, are top research priorities. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2026;14(4):102463. doi:10.1016/j.jvsv.2026.102463

BibTeX
@article{SachdevOst2026,
  author = {Sachdev-Ost, Ulka and Obi, Andrea and Fukaya, Eri and Chaar, Cassius Ochoa and Robinson, Scott and Rodriquez, Limael and Nguyen, Khan and Henke, Peter and Van Rij, Andre and Jacobs, Benjamin},
  title = {Results of the American Venous Forum research retreat on C2 disease confirms that the biology of varicose veins including etiology, progression, and novel therapeutics, as well as disparities, are top research priorities},
  journal = {Journal of Vascular Surgery: Venous and Lymphatic Disorders},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {102463},
  doi = {10.1016/j.jvsv.2026.102463}
}
Kostenlos starten →